Cited by

• Seroprevalence of human T-lymphotropic virus antibodies among patients with lymphoid malignancies at a tertiary center in Lagos, Nigeria.

  Akinbami A, Durojaiye I, Dosunmu A, John-Olabode S, Adediran A, Oshinaike O, Uche E, Dada A, Odesanya M, Okunoye O. Akinbami A, et al. J Blood Med. 2014 Sep 5;5:169-74. doi: 10.2147/JBM.S67912. eCollection 2014. J Blood Med. 2014. PMID: 25228827 Free PMC article.
• Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.

  Gonçalves DU, Proietti FA, Ribas JG, Araújo MG, Pinheiro SR, Guedes AC, Carneiro-Proietti AB. Gonçalves DU, et al. Clin Microbiol Rev. 2010 Jul;23(3):577-89. doi: 10.1128/CMR.00063-09. Clin Microbiol Rev. 2010. PMID: 20610824 Free PMC article. Review.
• Reduction of HTLV-I-infected cells in blood by leukocyte filtration.

  Al EJ, Visser SC, Broersen SM, Stienstra S, Huisman JG. Al EJ, et al. Ann Hematol. 1993 Dec;67(6):295-300. doi: 10.1007/BF01696350. Ann Hematol. 1993. PMID: 8280813
• Transmission of tropical and geographically restricted infections during solid-organ transplantation.

  Martín-Dávila P, Fortún J, López-Vélez R, Norman F, Montes de Oca M, Zamarrón P, González MI, Moreno A, Pumarola T, Garrido G, Candela A, Moreno S. Martín-Dávila P, et al. Clin Microbiol Rev. 2008 Jan;21(1):60-96. doi: 10.1128/CMR.00021-07. Clin Microbiol Rev. 2008. PMID: 18202437 Free PMC article. Review.
• Mother-to-Child Transmission of Human T-Cell Lymphotropic Viruses-1/2: What We Know, and What Are the Gaps in Understanding and Preventing This Route of Infection.

  Carneiro-Proietti AB, Amaranto-Damasio MS, Leal-Horiguchi CF, Bastos RH, Seabra-Freitas G, Borowiak DR, Ribeiro MA, Proietti FA, Ferreira AS, Martins ML. Carneiro-Proietti AB, et al. J Pediatric Infect Dis Soc. 2014 Sep;3 Suppl 1(Suppl 1):S24-9. doi: 10.1093/jpids/piu070. J Pediatric Infect Dis Soc. 2014. PMID: 25232474 Free PMC article.